Pterygium Surgery Consent Document

Patient consent is a legal requirement prior to any invasive surgical procedure. The basic concept is that the patient should be given all the relevant information to make a sound decision for himself/herself. Informed consent is defined as the process where the patient fully understands all the risks, benefits, alternatives and consequences of a proposed medical act. This is achieved through verbal and written disclosure of the same from the ophthalmologist to the patient.

What are the indications for pterygium excision?

An Ophthalmologist bayside is a benign non-cancerous growth of conjunctival tissue on the front surface of the eye. It is usually asymptomatic until it grows to the cornea and causes irritation and loss of vision. Treatment is essential as it not only improves the cosmetic appearance but also relieves discomfort and reduces ocular irritation.

Traditional “bare sclera” pterygium removal leaves the underlying white of the eye exposed and healing occurs over two to four weeks with moderate discomfort. However, a high rate of recurrence has been reported. Currently, a no-stitch technique allows the surgeon to remove the pterygium while leaving a layer of the autograft intact. This technique has significantly reduced recurrence rates and improved visual acuity after surgery.

All patients undergoing pterygium surgery should be carefully examined before the operation by an experienced ophthalmologist to ensure that it is safe for them and that they have adequate vision. The ophthalmologist should perform a detailed history and examination of the eye including visual acuity, extraocular movement testing and corneal evaluation. The patient should also be carefully instructed about the use of medicated drops/ointment and should be advised to wash the eyes regularly with water at noon, evening and before bedtime as directed.